8-K: Cryo-Cell International Faces Termination of Key License Agreement with Duke University

Cryo-Cell International received a termination notice from Duke University for their Patent and Technology License Agreement, citing a breach of contract.

Summary

• Cryo-Cell International, Inc. received a notice of termination from Duke University regarding their Patent and Technology License Agreement, effective May 17, 2025.
• The Duke License Agreement, originally effective February 23, 2021, granted Cryo-Cell exclusive rights to commercially exploit certain licensed products and processes for treating diseases in humans.
• Duke's termination notice is based on their claim that Cryo-Cell breached the Duke License Agreement.
• This termination follows Cryo-Cell's demand for arbitration against Duke, alleging fraudulent inducement and breach of contract.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the termination of a material agreement and ongoing legal dispute.

Negatives

• Cryo-Cell International has received a termination notice from Duke University for a key license agreement.
• Duke University claims that Cryo-Cell breached the Duke License Agreement.

Risks

• The termination of the Duke License Agreement could negatively impact Cryo-Cell's ability to develop and commercialize certain products and processes.
• The ongoing arbitration with Duke University could result in legal costs and an unfavorable outcome for Cryo-Cell.
• The loss of exclusive rights to certain licensed products and processes could affect Cryo-Cell's competitive position in the market.

Future Outlook

The future outlook for Cryo-Cell is uncertain due to the termination of the license agreement and the ongoing arbitration with Duke University.

Management Comments

• David Portnoy, Chairman and Co-CEO, signed the report on behalf of Cryo-Cell International, Inc.

Industry Context

License agreements are common in the biotechnology industry, and their termination can significantly impact a company's product development and commercialization efforts. Disputes over intellectual property and contract terms are also not uncommon.

Legal Proceedings

• Cryo-Cell has filed a demand for arbitration against Duke University with the American Arbitration Association, alleging fraudulent inducement and breach of contract.

Stakeholder Impact

• Shareholders may be concerned about the potential impact of the license agreement termination on Cryo-Cell's future prospects.
• Employees involved in the development and commercialization of the licensed products may be affected.
• Customers may experience changes in the availability or pricing of related products and services.

Next Steps

• Cryo-Cell will likely need to address the termination of the license agreement and continue with the arbitration process.
• Cryo-Cell may need to seek alternative technologies or partnerships to mitigate the impact of the termination.

Key Dates

Keywords

Cryo-Cell International, Duke University, License Agreement, Termination, Breach of Contract, Arbitration, Patent, Technology